ContactISSN:e-ISSN: 2757-976X
Author Sign-inReviewer Sign-inRegister
TürkçeEnglish
Home
About Journal
Copyright NoticeOpen Access PolicyAim and ScopePrinciples of ArbitrationReviewer and Editor GuideFee PolicyEthical Principles and Publication PolicyArchiving PolicyIndexing
Information For AuthorsEditorial BoardSend ArticleLatest IssueArchiveContact Us

Relationship of Metabolic Syndrome with Magnesium/Calcium Ratio and C-Reactive Protein-Albumin-Lymphocyte Index

latife uzun

  • latife uzun: KARAMAN İL SAĞLIK MÜDÜRLÜĞÜ 5 NOLU AİLE SAĞLIĞI MERKEZİ
  •  Year : 2026
  •  Vol : 6
  •  Issue : 1
  •  Page : 19-24
Aim:Metabolic syndrome(MetS) is associated with chronic inflammation,immune function and nutritional status. The C-reactive protein-albumin-lymphocyte(CALLY) index is a new index that may have prognostic value in various cancers and cardiovascular diseases.Magnesium(Mg) affects the functioning of many enzymes involved in glucose metabolism.Calcium(Ca) plays a key role in hypertension and obesity.This study aimed to investigate the relationship between MetS and serum Mg/Ca ratio and CALLY index. Methods:This study was done retrospectively on individuals over 18 years of age who applied to the Unit No.56 Family Medicine in Karaman Center between April 1,2023 and April 1,2025.Age,gender,smoking,blood pressure values,height,weight and waist circumference were evaluated.In addition,laboratory results such as fasting serum Mg,Ca,Hemoglobin A1c,low-density lipoprotein,high-density lipoprotein,total cholesterol,triglyceride,blood glucose,insulin,albumin,CRP levels and lymphocyte count were evaluated.Body mass index(BMI),Homeostasis Model Assessment(HOMA) and CALLY index were calculated with formulas.The diagnostic criteria for MetS recommended by the Turkish Society of Endocrinology and Metabolism were used for the diagnosis of MetS.Analysis was done using appropriate statistical methods. Results:MetS was detected in 24.5%(n=184) of the 750 people who participated in the study.The Mg/Ca ratio was lower in those with MetS.However,no statistically significant difference was observed.Although the power of the CALLY index to distinguish metabolic syndrome was weak,it was found to be statistically significant.Additionally,it was found that the risk of MetS increased by 1.05 times for each unit decrease in the CALLY index. Conclusions:The obtained data show that the CALLY index may provide additional value in identifying individuals at high risk of developing MetS.However,large-scale randomized studies are needed to fully define the biomarker's properties.
Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2026, Vol6, Issue1
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :

References

  1. 1. TEMD Türkiye Endokrinoloji ve Metabolizma Derneği Metabolik Sendrom Çalışma Grubu Metabolik Sendrom Kılavuzu 2009 Ankara, 2009: 7-14.
  2. 2. Fahed G, Aoun L, Zerdan MB, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786.
  3. 3. Hotamisligil GS. Foundations of Immunometabolism and Implications for Metabolic Health and Disease. In Immunity. Immunity. 2017;47(3):406-420.
  4. 4. Berbudi A, Rahmadika N, Tjahjadi AI, et al. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442-449.
  5. 5. Martin CA, Gowda U, Smith BJ, et al. Systematic Review of the Effect of Lifestyle Interventions on the Components of the Metabolic Syndrome in South Asian Migrants. J Immigr Minor Health. 2018;20(1):231-244.
  6. 6. Giugliano D, Ceriello A, Esposito K. The Effects of Diet on Inflammation. Emphasis on the Metabolic Syndrome. J Am Coll Cardiol. 2006;48(4):677-85.
  7. 7. Wu B, Liu J, Shao C, et al. Integrating inflammation, nutrition, and immunity: the CALLY index as a prognostic tool in digestive system cancers- a systematic review and meta-analysis. BMC Cancer. 2025;25(1):672.
  8. 8. Iida H, Tani M, Komeda K, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022;24(1):101-115.
  9. 9. Zhuang J, Wang S, Wang Y, et al. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer. Int J Gen Med. 2024:17:997-1005.
  10. 10. Wang W, Gu J, Liu Y, et al. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer Cancer Manag Res. 2022:14:2803-2812.
  11. 11. Han D, Wu L, Zhou H, et al. Associations of the C-reactive protein-albumin-lymphocyte index with all-cause and cardiovascular mortality among individuals with cardiovascular disease: evidence from the NHANES 2001-2010. BMC Cardiovasc Disord. 2025;25(1):144.
  12. 12. Ye J, Chen L, Xu D, et al. Inverse association between CALLY index and angina pectoris in US adults: a population-based study BMC Cardiovasc Disord. 2025;25(1):94.
  13. 13. Wu L, Han D, Xue Y, et al. Association between the C-reactive protein-albumin-lymphocyte index and metabolic syndrome: evidence from the 2003-2010 national health and nutrition examination survey. Diabetol Metab Syndr. 2025;17(1):39.
  14. 14. Pelczyńska M, Moszak M, Bogdański P. The Role of Magnesium in the Pathogenesis of Metabolic Disorders. Nutrients. 2022;14(9):1714.
  15. 15. Alsheikh R, Aldulaimi H, Hinawi R, et al. Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank. Nutr Metab (Lond). 2025;22(1):8.
  16. 16. Ozdemir S, Algın A. Interpretation Of the Area Under the Receiver Operating Characteristic Curve. Exp Appl Med Sci. 2022;3(1):310-1.
  17. 17. Corbacıoğlu ŞK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value. Turk J Emerg Med. 2023;23(4):195-198.
  18. 18. Barbagallo M., Dominguez LJ, Galioto A., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24(1-3):39-52.
  19. 19. Wan Nik WNFH, Zulkeflee HA, Ab Rahim SN, et al. Association of vitamin D and magnesium with insulin sensitivity and their influence on glycemic control. World J Diabetes. 2023;14(1):26-34.
  20. 20. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002;21(2):146S-151S. doi: 10.1080/07315724.2002.10719212.
  21. 21. Erinc O, Yesilyurt S. Relationship between serum magnesium levels and glycemic control and insulin resistance. North Clin Istanb. 2025;12(2):239-243.
  22. 22. Kumar P, Bhargava S, Agarwal P, et al. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Family Med Prim Care. 2019;8(5):1671-1677.
  23. 23. Saeed H, Haj S, Qasim B. Estimation of magnesium level in type 2 diabetes mellitus and its correlation with HbA1c level. Endocrinol Diabetes Metab. 2018;2(1): e00048.
  24. 24. Han D, Fang X, Su D, et al. Dietary Calcium Intake and the Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Sci Rep. 2019;9(1):19046.
  25. 25. Alsheikh R, Aldulaimi H, Hinawi R, et al. Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank. Nutr Metab (Lond). 2025;22(1):8.
  26. 26. Chen JM, Wu TY, Wu YF, et al. Association of the serum calcium level with metabolic syndrome and its components among adults in Taiwan. Arch Endocrinol Metab. 2023;67(5): e000632.
  27. 27. Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, et al. Role of Vitamin D in the Metabolic Syndrome. Nutrients. 2021;13(3):830.
  28. 28. Ince B, Yildirim MEC, Ismayilzade M, et al. Vitamin D and Systemic Effects of Vitamin D Deficiency. Selcuk Med J 2018;34(2):84-89.
  29. 29. Yıldırım Dİ, Marakoğlu K. Diyabet Hastalarında D. Vitamini ile Hba1c İlişkisinin Değerlendirilmesi. Selcuk Med J 2019;35(1):37-42.
  30. 30. Zenger GB, Eklioglu BS, Atabek ME, et al. Evaluation of The Relationship Between Metabolic Parameters, and Vitamin D Levels in Children with Insulin-Dependent Diabetes Mellitus. Selcuk Med J 2024;40(2):63-67.